ACXP
Acurx Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.42
+1.43%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-16.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 22, 2026 | LUCI DAVID P · director, officer: President and CEO | A-Award | 37,100 | $2.36 |
| Apr 22, 2026 | Scodari Joseph C · director | A-Award | 2,150 | $2.36 |
| Apr 22, 2026 | HARRISON THOMAS L · director | A-Award | 2,150 | $2.36 |
| Apr 22, 2026 | Donohue James J. · director | A-Award | 2,150 | $2.36 |
| Apr 22, 2026 | DEAN JACK H · director | A-Award | 2,150 | $2.36 |
| Apr 22, 2026 | Sailer Carl · director | A-Award | 2,150 | $2.36 |
| Apr 22, 2026 | Shawah Robert G. · officer: Chief Financial Officer | A-Award | 25,900 | $2.36 |
| Apr 22, 2026 | DELUCCIA ROBERT J · director | A-Award | 37,100 | $2.36 |
| Feb 6, 2025 | LUCI DAVID P · director, 10 percent owner, officer: President and CEO | A-Award | 250,000 | $0.80 |
| Feb 6, 2025 | Shawah Robert G. · officer: Chief Financial Officer | A-Award | 145,500 | $0.80 |
| Feb 6, 2025 | DELUCCIA ROBERT J · director, 10 percent owner: | A-Award | 250,000 | $0.80 |
| Jan 8, 2025 | Donohue James J. · director | Purchase | 9,852 | $1.01 |
| Jan 8, 2025 | Scodari Joseph C · director | Purchase | 24,631 | $1.01 |
| Jan 8, 2025 | Sailer Carl · director | Purchase | 24,631 | $1.01 |
| Jan 8, 2025 | LUCI DAVID P · director, 10 percent owner, officer: President and CEO | Purchase | 49,261 | $1.01 |
| Jan 8, 2025 | DELUCCIA ROBERT J · director, 10 percent owner: | Purchase | 49,261 | $1.01 |
| Jan 8, 2025 | DEAN JACK H · director | Purchase | 9,852 | $1.01 |
| Jun 18, 2024 | DEAN JACK H · director | A-Award | 12,000 | $2.38 |
| Jun 18, 2024 | Scodari Joseph C · director | A-Award | 12,000 | $2.38 |
| Jun 18, 2024 | Sailer Carl · director | A-Award | 12,000 | $2.38 |
| Jun 18, 2024 | HARRISON THOMAS L · director | A-Award | 12,000 | $2.38 |
| Jun 18, 2024 | Donohue James J. · director | A-Award | 12,000 | $2.38 |
| Apr 3, 2024 | Shawah Robert G. · officer: Chief Financial Officer | A-Award | 145,000 | $3.15 |
| Apr 3, 2024 | LUCI DAVID P · director, 10 percent owner, officer: President and CEO | A-Award | 250,000 | $3.15 |
| Apr 3, 2024 | DELUCCIA ROBERT J · director, 10 percent owner: | A-Award | 250,000 | $3.15 |
| Jan 22, 2024 | Sailer Carl · director | M-Exempt | 19,737 | $3.55 |
| Jan 4, 2024 | LUCI DAVID P · director, 10 percent owner, officer: President and CEO | M-Exempt | 19,737 | $3.55 |
| Jan 4, 2024 | DELUCCIA ROBERT J · director, 10 percent owner: | M-Exempt | 19,737 | $3.55 |
| Jun 16, 2023 | DEAN JACK H · director | A-Award | 10,000 | $2.75 |
| Jun 16, 2023 | Sailer Carl · director | A-Award | 10,000 | $2.75 |
Institutional positioning
13F filings over the trailing two quarters
New 8Increased 3Reduced 5Sold out 21
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JANE STREET GROUP, LLC | Increased | 54,642 | May 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 31,099 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 24,819 | May 15, 2026 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | New Position | 20,000 | Apr 30, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 16,205 | May 8, 2026 |
| PROSPECT FINANCIAL SERVICES LLC | Reduced | 13,785 | Apr 24, 2026 |
| MORGAN STANLEY | Reduced | 6,500 | May 15, 2026 |
| UBS GROUP AG | Increased | 6,312 | May 5, 2026 |
| WELLS FARGO & COMPANY/MN | Unchanged | 2,300 | Jul 8, 2026 |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | New Position | 1,650 | May 4, 2026 |
| NBC SECURITIES, INC. | Unchanged | 1,500 | Apr 14, 2026 |
| WESTERN WEALTH MANAGEMENT, LLC | New Position | 1,325 | May 19, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Reduced | 1,031 | May 15, 2026 |
| MCGUIRE CAPITAL ADVISORS INC | New Position | 1,000 | May 14, 2026 |
| BARCLAYS PLC | New Position | 380 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 22, 2026